https://q.futunn.com/en/feed/116168094187524
China Merchants Securities: Abbisko (2256.HK, Buy) Enters Fi... - Futubull Community
Pimitespib:$ABBISKO-B (02256.HK)$Expected to receive several milestone payments in 2026, along with the start of continuous commercial revenue Followi...
chinamerchantssecurities
https://hkbusinesswire.com/abbisko-therapeutics-announces-china-nmpa-acceptance-of-new-drug-application-for-pimicotinib-for-the-treatment-of-tgct/
Abbisko Therapeutics Announces China NMPA Acceptance of New Drug Application for Pimicotinib for...
Jun 10, 2025 - SHANGHAI, June 10, 2025 /PRNewswire/ -- Abbisko Therapeutics Co., Ltd. (02256.HK) today announced that the China National Medical Products Administration